Cancer of the testis: A new paradigm

Research output: Contribution to journalReview article

7 Citations (Scopus)

Abstract

Not long ago, disseminated disease was almost invariably fatal, but now patients with metastatic as well as localized tumors are routinely cured at rates of 90% or more. Development of synergistic platinum-based regimens, administered in high doses for short periods, spearheaded the breakthrough. When properly timed, radiotherapy and surgery remain important and effective modalities.

Original languageEnglish (US)
Pages (from-to)165-178
Number of pages14
JournalHospital Practice
Volume21
Issue number4
StatePublished - Jan 1 1986

Fingerprint

Testicular Neoplasms
Platinum
Radiotherapy
Neoplasms

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Cancer of the testis : A new paradigm. / Einhorn, L. H.

In: Hospital Practice, Vol. 21, No. 4, 01.01.1986, p. 165-178.

Research output: Contribution to journalReview article

Einhorn, L. H. / Cancer of the testis : A new paradigm. In: Hospital Practice. 1986 ; Vol. 21, No. 4. pp. 165-178.
@article{af25f7a32e9740fc9b58a1fb0cf0c475,
title = "Cancer of the testis: A new paradigm",
abstract = "Not long ago, disseminated disease was almost invariably fatal, but now patients with metastatic as well as localized tumors are routinely cured at rates of 90{\%} or more. Development of synergistic platinum-based regimens, administered in high doses for short periods, spearheaded the breakthrough. When properly timed, radiotherapy and surgery remain important and effective modalities.",
author = "Einhorn, {L. H.}",
year = "1986",
month = "1",
day = "1",
language = "English (US)",
volume = "21",
pages = "165--178",
journal = "Hospital practice (1995)",
issn = "2154-8331",
publisher = "Taylor and Francis Ltd.",
number = "4",

}

TY - JOUR

T1 - Cancer of the testis

T2 - A new paradigm

AU - Einhorn, L. H.

PY - 1986/1/1

Y1 - 1986/1/1

N2 - Not long ago, disseminated disease was almost invariably fatal, but now patients with metastatic as well as localized tumors are routinely cured at rates of 90% or more. Development of synergistic platinum-based regimens, administered in high doses for short periods, spearheaded the breakthrough. When properly timed, radiotherapy and surgery remain important and effective modalities.

AB - Not long ago, disseminated disease was almost invariably fatal, but now patients with metastatic as well as localized tumors are routinely cured at rates of 90% or more. Development of synergistic platinum-based regimens, administered in high doses for short periods, spearheaded the breakthrough. When properly timed, radiotherapy and surgery remain important and effective modalities.

UR - http://www.scopus.com/inward/record.url?scp=0022448981&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022448981&partnerID=8YFLogxK

M3 - Review article

C2 - 2420812

AN - SCOPUS:0022448981

VL - 21

SP - 165

EP - 178

JO - Hospital practice (1995)

JF - Hospital practice (1995)

SN - 2154-8331

IS - 4

ER -